XML 12 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Balance Sheets - USD ($)
Jun. 30, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 4,483,400 $ 4,375,300
Marketable securities 317,200
Accounts receivable, net 466,700 417,300
Prepaid expenses and other current assets 136,000 48,500
Total current assets 5,403,300 4,841,100
Property and equipment, net 2,900
Other assets 17,800 17,800
Total assets 5,424,000 4,858,900
Current liabilities    
Accounts payable 248,600 251,000
Accrued expenses 64,400 82,000
Accrued wages 143,500 141,600
Deferred revenue 1,180,200 1,084,900
Total current liabilities 1,636,700 1,559,500
Long-term liabilities    
Deferred revenue 343,000 383,000
Total liabilities 1,979,700 1,942,500
Commitments and contingencies
Stockholders’ equity    
Preferred stock, $0.01 par value, 5,000,000 shares authorized, no shares issued and outstanding as of June 30, 2021 or December 31, 2020
Common stock, $0.0001 par value, 195,000,000 shares authorized, 18,850,675 shares issued and outstanding for both periods ending June 30, 2021 and December 31, 2020 1,900 1,900
Additional paid-in capital 82,155,200 82,155,200
Accumulated deficit (78,712,800) (79,240,700)
Total stockholders’ equity 3,444,300 2,916,400
Total liabilities and stockholders’ equity $ 5,424,000 $ 4,858,900